Cuban scientist Amílcar Pérez Riverol sounded the alarm: “This needs an URGENT explanation. Press dispatches citing the Minister of Health Iranian Said Namaki reported yesterday that that country approved the emergency use of Sovereign 02. This would be other good news if it weren’t for the way it has been portrayed, “he wrote on Twitter.
According to the researcher, who has been doing analysis on the evolution of the pandemic of the Covid-19 and the development of vaccine candidates Cubans against the virus, Information about the Iranian Pastu Covac vaccine, developed by the Pasteur Institute of Tehran in collaboration with the Finlay Vaccine Institute of Havana, refers to the drug as developed in that Asian country.
“It is one thing to transfer technology and another to talk about a vaccine developed and manufactured in Iran”, Pérez Riverol warned.
According to Iranian media, Minister Namaki said that the vaccine developed by Iran’s Pasteur Institute had obtained emergency use approval after successfully completing the third stage of clinical trials.
“The third phase of the clinical trial of the Pasteur vaccine, which is the second Iranian vaccine against the coronavirus and today we were able to obtain permission for its emergency use from the legal committee, “the official announced, according to the Iranian media. Press TV.
That report, however, assures that the injectable was “developed as part of a joint experiment with Cuban scientists.”
Own Namaki had said in mid-June that the Iran Pasteur was going to be authorized shortly. “Pasteur, which is one of the best vaccines with the technology in common of our country with Cuba, you will get permission for your emergency use early next week. “he said then, according to the AP report.
“The AstraZeneca-Oxford vaccine (AZD1222- ChadOx-1, Vaxzevria), for example, is produced and marketed by the Serum Institute of India under an alternative name (Covishield), but no one would think of talking about a vaccine developed in the India, “stressed the Cuban scientist when questioning the information on the matter.
“Is it a communication error or something more serious?” Pérez Riverol wondered, to finish its publication.
None of the state entities responsible for Sovereign 02, still in phase three of its clinical trials in Cuba, although administered to many people as part of the so-called “health intervention” carried out by the Cuban Ministry of Public Health (MINSAP), have referred to the matter. Not even the official Cuban media have reported the approval of vaccination with the drug in the allied country.
Iran had approved its own Coviran Barekat vaccine for emergency use in early June, news that was widely reviewed in Cuba. Likewise, production of the Sputnik V vaccine from Russia recently began in the country.
Tehran expects the number of vaccinated to reach 13 million by mid-August.
Iran has three other vaccine candidates against the novel coronavirus, including two developed by armed forces scientists and one by the Razi Vaccine and Serum Research Institute, a government-run pharmaceutical company.
Last January, Havana and Tehran signed a bilateral agreement to transfer technology to the Asian nation for the production of Soberna 02 Y to develop third-stage clinical trials in that country.
But, according to the half russian Sputnik, “As early as April the spokesman for the Iranian Food and Drug Administration, Kianoush Jahanpour, said that the vaccine was created by the Pasteur Institute. In recent months the Iranian media has called it simply ‘Pasteur vaccine’.”
– .
